Plexus (NASDAQ:PLXS) CEO Sells 1,500 Shares of Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $242.41, for a total transaction of $363,615.00. Following the transaction, the chief executive officer directly owned 64,388 shares of the company’s stock, valued at approximately $15,608,295.08. This represents a 2.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Price Performance

NASDAQ PLXS traded up $3.41 on Thursday, hitting $245.74. The stock had a trading volume of 158,023 shares, compared to its average volume of 318,666. Plexus Corp. has a 52-week low of $132.03 and a 52-week high of $307.06. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. The company has a market capitalization of $6.58 billion, a price-to-earnings ratio of 36.24 and a beta of 0.89. The firm has a 50-day moving average of $253.29 and a 200-day moving average of $248.22.

Plexus (NASDAQ:PLXS) last released its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping the consensus estimate of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter in the prior year, the firm posted $1.64 earnings per share. The business’s quarterly revenue was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities analysts expect that Plexus Corp. will post 7.11 EPS for the current year.

Wall Street Analyst Weigh In

PLXS has been the topic of a number of recent analyst reports. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research note on Friday, July 31st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Weiss Ratings downgraded shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, September 9th. Stifel Nicolaus upped their target price on shares of Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Finally, Needham & Company LLC reissued a “buy” rating and issued a $310.00 target price on shares of Plexus in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Plexus presently has an average rating of “Buy” and an average price target of $273.00.

Hedge Funds Weigh In On Plexus

Several institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in shares of Plexus during the second quarter valued at approximately $1,311,631,000. Geode Capital Management LLC raised its holdings in Plexus by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 672,614 shares of the technology company’s stock valued at $98,890,000 after buying an additional 4,054 shares during the last quarter. Bank of America Corp DE bought a new stake in Plexus during the 2nd quarter valued at $60,281,000. Bank of New York Mellon Corp purchased a new stake in Plexus during the 2nd quarter valued at $55,525,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in Plexus in the 2nd quarter worth $35,755,000. 94.45% of the stock is currently owned by institutional investors.

Plexus Company Profile

Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.

Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.